Abviva, Inc. (AVVA.OB) is “One to Watch”
Abviva, Inc. (AVVA.OB), a biomedical company that specializes in the development and commercialization of diagnostic and therapeutic products from mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth, was recently noted as a stock to watch. Abviva’s research focuses on developing innovative breast cancer diagnostic and therapeutic products that can benefit individuals throughout the world. Abviva’s growth strategy is to develop a fully integrated diagnostic and therapeutic business that is sustained by product and services revenues. Additionally, the company plans to commercialize the Mammastatin Serum Assay, which measures a woman’s risk of developing breast cancer, through its wholly owned…